Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver transplantation. Current aspects]

O Soubrane1, D Houssin

  • 1Clinique Chirurgicale, Hôpital Cochin, Paris.

Presse Medicale (Paris, France : 1983)
|February 3, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended left hepatectomy with inferior vena cava reconstruction and veno-venous bypass for alveolar echinococcosis (with video).

Journal of visceral surgery·2022
Same author

[Health, a matter of State].

Bulletin de l'Academie nationale de medecine·2022
Same author

The first year of Junior Doctors in visceral and digestive surgery in France: For what position and with which function?

Journal of visceral surgery·2022
Same author

Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.

The British journal of surgery·2021
Same author

Practical model to identify liver transplant recipients at low risk of postoperative haemorrhage, bile leakage and ascites.

BJS open·2021
Same author

History of first transplantations: Nothing is ever written. Part II.

Journal of visceral surgery·2021
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Liver transplantation advancements include graft splitting and new immunosuppressants like tacrolimus. Future alternatives to liver transplants involve xenografting and bioartificial liver devices.

Area of Science:

  • Hepatology and Transplant Surgery
  • Immunology
  • Medical Ethics and Policy

Background:

  • Liver transplantation has seen significant technical innovations, including graft reduction/splitting and living donor use.
  • Immunosuppression strategies are evolving with new drugs like tacrolimus (FK 506) showing promise for severe rejections.
  • Clinical outcomes have prompted a re-evaluation of liver transplantation indications.

Purpose of the Study:

  • To review the advancements in liver transplantation techniques and immunosuppression.
  • To discuss the evolving indications and regulatory framework for liver transplantation.
  • To explore future alternatives to allogeneic liver transplantation.

Main Methods:

  • Review of technical refinements in liver graft utilization.

Related Experiment Videos

  • Evaluation of emerging immunosuppressive agents.
  • Analysis of updated clinical indications and regulatory measures.
  • Exploration of potential future therapeutic strategies.

    • Main Results:

    • Technical refinements such as graft splitting and auxiliary grafts enhance liver transplantation utility.
    • Tacrolimus (FK 506) is under evaluation for managing severe graft rejection.
    • The establishment of the Etablissement Français des Greffes in France highlights regulatory development for organ transplantation.
    • Future alternatives include xenotransplantation, hepatic assistance, bioartificial livers, and gene therapy.

    Conclusions:

    • Liver transplantation has evolved significantly with technical and pharmacological advancements.
    • Regulatory bodies play a crucial role in managing and overseeing transplantation activities.
    • Emerging technologies offer promising alternatives to traditional liver allografts.